BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33649811)

  • 21. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
    Wang X; Li X; Wang Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
    Liao Z; Zhao J; Yang Y
    Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.
    Chen S; Chen H; Wang X; Zhang D; Zhang L; Cheng J; Zhang Q; Hua Z; Miao X; Shi J
    An Bras Dermatol; 2024; 99(4):535-545. PubMed ID: 38548549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
    Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
    Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
    Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
    J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
    Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
    Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
    Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
    Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00460 Promotes Cutaneous Squamous Cell Carcinoma Progression Through Stabilizing ELAVL1 Protein.
    Xue C; Yang Z; Yang B; Xiong H; Ye W
    Mol Biotechnol; 2023 Aug; 65(8):1296-1305. PubMed ID: 36513874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 32. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
    Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer.
    Gan L; Lv L; Liao S
    Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function.
    Zhao Y; Feng C; Li Y; Ma Y; Cai R
    Mol Cell Biochem; 2019 Oct; 460(1-2):1-8. PubMed ID: 31187349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA‑675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin.
    Liu K; Jin J; Rong K; Zhuo L; Li P
    Mol Med Rep; 2018 Feb; 17(2):3372-3379. PubMed ID: 29257296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.